Overview

Memantine Augmentation in Obsessive-Compulsive Disorder

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether memantine is safe and effective when used as an augmentation to standard treatment for Obsessive-Compulsive Disorder (OCD).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Stanford University
Treatments:
Memantine